Please assess the completion status of the following clinical trial:

Trial Title: EEG Cap for Identification of Non-Convulsive Status Epilepticus

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion criteria:~1. Patients with suspected NCSE in the Mayo Clinic Florida hospital, emergency room or intensive care unit.~2. Age: Patients of 18 years or older will be included in this study~3. Education: All education levels will be included~Exclusion criteria:~1. Patients younger than 18 years of age.~2. Patients with open head trauma.~3. Patients with anatomy that would preclude EEG cap placement.~4. Patients excluded for anatomical or age-related reasons will be tracked to determine applicability of the EEG cap to the patient population at Mayo Clinic.~5. Pregnant females~6. Large head size not amenable to cap placement~7. Scalp infection~8. Inability to obtain informed consent

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- EEG Cap (Type: OTHER): Single arm study, where every participant gets assessed by EEG cap and then standard EEG. Some subjects may be treated with anti-seizure medications before standard EEG, due to ethical responsibility, if clear NCSE is identified on cap EEG. If the subject is treated with anti-seizure medication, the primary care provider will choose which medication will be given.

Based on this trial design, predict the completion outcome and termination type (if applicable).